VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $795,531 | -5.3% | 34,187 | +3.0% | 0.03% | -33.3% |
| Q4 2022 | $839,988 | -41.2% | 33,188 | -55.2% | 0.04% | -15.2% |
| Q3 2022 | $1,429,000 | +35.5% | 74,076 | +82.7% | 0.05% | +48.4% |
| Q2 2022 | $1,055,000 | +1.4% | 40,546 | +1.0% | 0.03% | +47.6% |
| Q1 2022 | $1,040,000 | -35.3% | 40,132 | +1.5% | 0.02% | -34.4% |
| Q4 2021 | $1,607,000 | -21.9% | 39,556 | -17.1% | 0.03% | -17.9% |
| Q3 2021 | $2,058,000 | +15.2% | 47,691 | +24.3% | 0.04% | +34.5% |
| Q2 2021 | $1,786,000 | -4.5% | 38,359 | -2.0% | 0.03% | -12.1% |
| Q1 2021 | $1,871,000 | +7.2% | 39,157 | -36.8% | 0.03% | -13.2% |
| Q4 2020 | $1,745,000 | -32.8% | 61,961 | -10.0% | 0.04% | -53.7% |
| Q3 2020 | $2,596,000 | +263.1% | 68,808 | +249.4% | 0.08% | +228.0% |
| Q2 2020 | $715,000 | – | 19,695 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |